Equities

Fuse Medical Inc

FZMD:PKL

Fuse Medical Inc

Actions
FinancialsInvestment Banking and Brokerage Services
  • Price (USD)0.046
  • Today's Change0.00 / 0.00%
  • Shares traded3.03k
  • 1 Year change-61.98%
  • Beta-1.0195
Data delayed at least 15 minutes, as of Aug 28 2024 18:58 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Fuse Medical Inc has grown net income from a loss of 1.59m to a gain of 3.10m despite declining revenues.
Gross margin64.95%
Net profit margin19.72%
Operating margin-1.30%
Return on assets18.91%
Return on equity--
Return on investment48.45%
More ▼

Cash flow in USDView more

In 2022, cash reserves at Fuse Medical Inc fell by 405.34k. However, the company earned 34.80k from its operations for a Cash Flow Margin of 0.19%. In addition the company paid out 440.14k more in cash than they received while cash form investing activities were even.
Cash flow per share0.0462
Price/Cash flow per share0.9216
Book value per share-0.0031
Tangible book value per share-0.0451
More ▼

Balance sheet in USDView more

Fuse Medical Inc has a Debt to Total Capital ratio of 111.64%.
Current ratio1.06
Quick ratio0.3143
Total debt/total equity--
Total debt/total capital1.12
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 276.22%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
EPS growth(5 years)2.06
EPS (TTM) vs
TTM 1 year ago
236.91
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.